Uptake Low for Monoclonal Antibodies for COVID-19
Use peaked in January and declined in early 2021, at the time of the vaccine rollout
Viral Infections
Remdesivir Cuts Risk of Hospitalization in COVID-19 Patients at Risk for Disease Progression
The trial included 584 nonhospitalized patients diagnosed with COVID-19 who were considered at high risk for disease progression based on comorbidities and age.
Moderna Vaccine Top for Protection Against COVID-19 Hospitalization
Vaccine effectiveness higher for Moderna than Pfizer-BioNTech vaccine; both mRNA vaccines have higher VE than Janssen
FDA Clears First-of-its-Kind Test to Distinguish Between Bacterial and Viral Infections
MeMed BV runs on the MeMed Key platform and provides results within 15 minutes.
Allergic Reactions to mRNA COVID-19 Vaccines Characterized
20 of 22 patients with suspected allergic reactions were women; 17 met Brighton anaphylaxis criteria
Lower Dose COVID-19 Vaccine Appears Safe, Immunogenic in Children 5 to 11 Years Old
Participants 5 to 11 years of age received a 2-dose regimen of 10mcg administered 21 days apart.
COVID-19 Vaccine Booster Dose Cuts Infection in Those 60 and Older
Large Israeli study shows reduction in confirmed infection and severe illness among adults 60 years of age and older
Bamlanivimab Plus Etesevimab Authorized for Postexposure Prophylaxis for COVID-19
Postexposure prophylaxis with bamlanivimab plus etesevimab is not a substitute for vaccination against COVID-19.
COVID-19 Vaccine Effectiveness Changing With Delta Predominance
Vaccine protection against SARS-CoV-2 infection declined; protection remained higher against hospitalization, death
USPSTF Updates Recommendations for Chlamydia, Gonorrhea Screening
Screening recommended for all women aged 24 years and younger and those aged 25 years and older at increased infection risk
